Bevenopran,
676500-67-7,
UNII-IC58Q2EHPJ,
5-(2-Methoxy-4-(((2-(tetrahydro-2H-pyran-4-yl)ethyl)amino)methyl)phenoxy)pyrazine-2-carboxamide,
IC58Q2EHPJ,
2-PYRAZINECARBOXAMIDE, 5-[2-METHOXY-4-[[[2-(TETRAHYDRO-2H-PYRAN-4-YL)ETHYL]AMINO]METHYL]PHENOXY]-,
Bevenopran [USAN:INN],
Bevenopran (USAN/INN),
SCHEMBL1462219,
CHEMBL3039511,
KS-00000TGY,
DTXSID90217963,
ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,
CB5945,
MFCD26967979,
ZINC38896576,
AKOS027254823,
CB5-945,
DB12464,
SB16949,
AK205674,
DS-10418,
HY-100122,
CS-0018101,
A17110,
D10349,
5-(2-Methoxy-4-{[2-(tetrahydropyran-4-yl)ethylamino]methyl}phenoxy)pyrazine-2-carboxamide,
2-Pyrazinecarboxamide, 5-(2-methoxy-4-(((2-(tetrahydro-2H-pyran-4- yl)ethyl)amino)methyl)phenoxy)-,
5-(2-Methoxy-4-(((2-(tetrahydro-2H-pyran-4-yl)ethyl)amino)methyl)phenoxy)pyrazine-2- carboxamide,
5-[2-Methoxy-4-[[[2-(tetrahydro-2H-pyran-4-yl)ethyl]amino]methyl]phenoxy]-2-pyrazinecarboxamide,
Bevenopran [USAN],
CID10452732,
5-[2-methoxy-4-[[2-(oxan-4-yl)ethylamino]methyl]phenoxy]pyrazine-2-carboxamide,